Cargando…
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
Despite advances in treatments and improved survival, patients with pulmonary hypertension still experience poor exercise and functional capacity, which has a significant detrimental impact on their quality of life. The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine 3′,5′-monopho...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402909/ https://www.ncbi.nlm.nih.gov/pubmed/28458514 http://dx.doi.org/10.2147/DDDT.S117277 |